Nima Sharifi1, Elaine M Hurt, Brian T Kawasaki, William L Farrar. 1. Cancer Stem Cell Section, Laboratory of Cancer Prevention, National Cancer Institute at Frederick, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA. nima.sharifi@nih.gov
Abstract
BACKGROUND: Resistance to transforming growth factor-beta (TGF-beta) is important in tumorigenesis. TGF-beta resistance mechanisms in prostate cancer are not well understood. METHODS: We have conducted a systematic analysis of TGF-beta pathway components with a meta-analysis of seven microarray studies using Oncomine and evaluated the results of TGFBR3 expression in prostate cell lines. Furthermore, we knocked down TGFBR3 in prostate epithelial cells and analyzed the consequences of TGFBR3 knockdown. RESULTS: We found that TGFBR3 is the TGF-beta component most commonly downregulated among localized human prostate cancer studies. TGFBR3 knockdown led to focus formation and enhanced expression of CD133, a marker found on prostate cancer stem cells. DNA microarray analysis of TGFBR3 knockdown cells identified 101 genes regulated by TGFBR3. Seven of these genes show a corresponding decrease in clinical prostate cancer specimens, which include genes involved in prostate mass and vasculature. CONCLUSIONS: TGFBR3 downregulation is an important step in prostate tumorigenesis. (c) 2006 Wiley-Liss, Inc.
BACKGROUND: Resistance to transforming growth factor-beta (TGF-beta) is important in tumorigenesis. TGF-beta resistance mechanisms in prostate cancer are not well understood. METHODS: We have conducted a systematic analysis of TGF-beta pathway components with a meta-analysis of seven microarray studies using Oncomine and evaluated the results of TGFBR3 expression in prostate cell lines. Furthermore, we knocked down TGFBR3 in prostate epithelial cells and analyzed the consequences of TGFBR3 knockdown. RESULTS: We found that TGFBR3 is the TGF-beta component most commonly downregulated among localized humanprostate cancer studies. TGFBR3 knockdown led to focus formation and enhanced expression of CD133, a marker found on prostate cancer stem cells. DNA microarray analysis of TGFBR3 knockdown cells identified 101 genes regulated by TGFBR3. Seven of these genes show a corresponding decrease in clinical prostate cancer specimens, which include genes involved in prostate mass and vasculature. CONCLUSIONS:TGFBR3 downregulation is an important step in prostate tumorigenesis. (c) 2006 Wiley-Liss, Inc.
Authors: Latha Ramdas; Uma Giri; Cheryl L Ashorn; Kevin R Coombes; Adel El-Naggar; K Kian Ang; Michael D Story Journal: Head Neck Date: 2009-05 Impact factor: 3.147
Authors: S J Cooper; H Zou; S N Legrand; L A Marlow; C A von Roemeling; D C Radisky; K J Wu; N Hempel; V Margulis; H W Tun; G C Blobe; C G Wood; J A Copland Journal: Oncogene Date: 2010-03-08 Impact factor: 9.867
Authors: Melissa Rotunno; Nan Hu; Hua Su; Chaoyu Wang; Alisa M Goldstein; Andrew W Bergen; Dario Consonni; Angela C Pesatori; Pier Alberto Bertazzi; Sholom Wacholder; Joanna Shih; Neil E Caporaso; Phil R Taylor; Maria Teresa Landi Journal: Cancer Prev Res (Phila) Date: 2011-07-08
Authors: Mohummad Minhaj Siddiqui; Kathryn M Wilson; Mara M Epstein; Jennifer R Rider; Neil E Martin; Meir J Stampfer; Edward L Giovannucci; Lorelei A Mucci Journal: J Clin Oncol Date: 2014-09-20 Impact factor: 44.544
Authors: Ivan P Gorlov; Jinyoung Byun; Olga Y Gorlova; Ana M Aparicio; Eleni Efstathiou; Christopher J Logothetis Journal: BMC Med Genomics Date: 2009-08-04 Impact factor: 3.063